Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.eclinm.2021.101025 http://scihub22266oqcxt.onion/10.1016/j.eclinm.2021.101025 34278287!8276632!34278287     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       EClinicalMedicine 2021 ; 38 (ä): 101025 Nephropedia Template TP {{tp|p=34278287|t=2021. Impact of COVID-19 on liver transplant recipients-A systematic review and meta-analysis |pdf=|usr=}}{{34278287}} gab.com Text Impact of COVID-19 on liver transplant recipients-A systematic review and meta-analysis JO: EClinicalMedicine http://www.kidney.de/pget.php?&tw=1&pmid=34278287 #FOAvip BACKGROUND: Immunosuppression and comorbidities increase the risk of severe coronavirus disease-2019 (COVID-19) in solid organ transplant (SOT) recipients. The outcomes of COVID-19 in liver transplant (LT) recipients remain unclear. We aimed to analyse the outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in LT recipients. METHODS: The electronic databases were searched for articles published from 1 December 2019 to 20 May 2021 with MeSH terms COVID-19, SARS-CoV-2, and liver transplantation. Studies reporting outcomes in more than 10 LT recipients were included for analysis. LT vs non-LT patients with COVID-19 infection were compared for all-cause mortality, which was the primary outcome studied. We also evaluated the relation between the timing of COVID-19 infection post-LT (< one year vs > one year) and mortality. FINDINGS: Eighteen articles reporting 1,522 COVID-19 infected LT recipients were included for the systematic review. The mean age (standard deviation [SD]) was 60.38 (5.24) years, and 68.5% were men. The mean time (SD) to COVID-19 infection was 5.72 (1.75) years. Based on 17 studies (I(2) = 7.34) among 1,481 LT recipients, the cumulative incidence of mortality was 17.4% (95% confidence interval [CI], 15.4-19.6). Mortality was comparable between LT (n = 610) and non-LT (n = 239,704) patients, based on four studies (odds ratio [OR], 0.8 [0.6-1.08]; P = 0.14). Additionally, there was no significant difference in mortality between those infected within one year vs after one year of LT (OR, 1.5 [0.63-3.56]; P = 0.35). The cumulative incidence of graft dysfunction was 2.3% (1.3-4.1). Nearly 23% (20.71-25) of the LT patients developed severe COVID-19 infection. Before infection, 71% and 49% of patients were on tacrolimus and mycophenolate mofetil, respectively. Immunosuppression was modified in 55.9% (38.1-72.2) patients after COVID-19 infection. INTERPRETATION: LT and non-LT patients with COVID-19 have a similar risk of adverse outcomes. Twit Text FOAVip Impact of COVID-19 on liver transplant recipients-A systematic review and meta-analysis ????EClinicalMedicine http://www.kidney.de/pget.php?&tw=1&pmid=34278287 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34278287 #FOAvip English Wikipedia <ref>{{Cite pmid|34278287}}</ref> Impact of COVID-19 on liver transplant recipients-A systematic review and meta-analysis #MMPMID34278287 Kulkarni AV; Tevethia HV; Premkumar M; Arab JP; Candia R; Kumar K; Kumar P; Sharma M; Rao PN; Reddy DN EClinicalMedicine 2021[Aug]; 38 (ä): 101025 PMID34278287show ga BACKGROUND: Immunosuppression and comorbidities increase the risk of severe coronavirus disease-2019 (COVID-19) in solid organ transplant (SOT) recipients. The outcomes of COVID-19 in liver transplant (LT) recipients remain unclear. We aimed to analyse the outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in LT recipients. METHODS: The electronic databases were searched for articles published from 1 December 2019 to 20 May 2021 with MeSH terms COVID-19, SARS-CoV-2, and liver transplantation. Studies reporting outcomes in more than 10 LT recipients were included for analysis. LT vs non-LT patients with COVID-19 infection were compared for all-cause mortality, which was the primary outcome studied. We also evaluated the relation between the timing of COVID-19 infection post-LT (< one year vs > one year) and mortality. FINDINGS: Eighteen articles reporting 1,522 COVID-19 infected LT recipients were included for the systematic review. The mean age (standard deviation [SD]) was 60.38 (5.24) years, and 68.5% were men. The mean time (SD) to COVID-19 infection was 5.72 (1.75) years. Based on 17 studies (I(2) = 7.34) among 1,481 LT recipients, the cumulative incidence of mortality was 17.4% (95% confidence interval [CI], 15.4-19.6). Mortality was comparable between LT (n = 610) and non-LT (n = 239,704) patients, based on four studies (odds ratio [OR], 0.8 [0.6-1.08]; P = 0.14). Additionally, there was no significant difference in mortality between those infected within one year vs after one year of LT (OR, 1.5 [0.63-3.56]; P = 0.35). The cumulative incidence of graft dysfunction was 2.3% (1.3-4.1). Nearly 23% (20.71-25) of the LT patients developed severe COVID-19 infection. Before infection, 71% and 49% of patients were on tacrolimus and mycophenolate mofetil, respectively. Immunosuppression was modified in 55.9% (38.1-72.2) patients after COVID-19 infection. INTERPRETATION: LT and non-LT patients with COVID-19 have a similar risk of adverse outcomes. äImpact of COVID-19 on liver transplant recipients-A systematic review (epmc).pdf DeepDyve Pubget Overpricing